Jenburkt Pharmaceuticals Ltd. (JENBURPH)
Market Open
5 Aug, 22:00
MSE MSE Primary ₹
1,111. 35
+11.3
+1.0272%
₹
4.45B Market Cap
20.75 P/E Ratio
72% Div Yield
1,371 Volume
0 Eps
₹ 1,100.05
Previous Close Want to track JENBURPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
JENBURPH trading today higher at ₹1,111.35, an increase of 1.0272% from yesterday's close, completing a monthly decrease of -1.5503% or -₹17.5. Over the past 12 months, JENBURPH stock gained 2.0523%.
JENBURPH pays dividends to its shareholders, with the most recent payment made on Aug 17, 2025. The next announced payment will be in In 3 weeks on Aug 28, 2026 for a total of ₹20.7.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 12.1563%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Jenburkt Pharmaceuticals Ltd. (JENBURPH) FAQ
What is the stock price today?
The current price is ₹1,111.35.
On which exchange is it traded?
Jenburkt Pharmaceuticals Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is JENBURPH.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 72%.
What is its market cap?
As of today, the market cap is 4.45B.
Has Jenburkt Pharmaceuticals Ltd. ever had a stock split?
No, there has never been a stock split.
Jenburkt Pharmaceuticals Ltd. Profile
| Health Care Technology Industry | Healthcare Sector | - CEO | MSE Exchange | INE354A01013 ISIN |
| India Country | 779 Employees | 28 Aug 2026 Last Dividend | - Last Split | - IPO Date |
Jenburkt Pharmaceuticals Ltd. is a prominent company in the pharmaceutical sector, headquartered in India. Its primary function is to research, manufacture, and market pharmaceutical products and formulations. The company's product portfolio encompasses a wide range of therapeutic categories, including analgesics, antibiotics, cardiology, and dermatology products, among others. Jenburkt Pharmaceuticals Ltd. serves the healthcare industry by supplying essential medicines that contribute to the well-being of patients across India and in various international markets. The firm's commitment to quality and innovation ensures its compliance with pertinent industry standards and regulations. In the financial market, Jenburkt Pharmaceuticals Ltd. plays a significant role as it enables investors to gain exposure to the diverse and continually growing pharmaceutical industry, reflecting on its stability and potential for consistent performance.
Contact Information
Address: Nirmala Apartments
Phone: 91 22 6760 3603
Website: https://jenburkt.com
